HORAN Wealth’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13K Hold
41,590
– – ﹤0.01% 350
2026
Q2
$17.8K Hold
41,590
– – ﹤0.01% 214
2026
Q1
$54.1K Buy
+41,590
New +$48.2K 0.01% 196

Other funds holding HRTX

HORAN Wealth's HRTX Position: Q3 2026 in Review

HORAN Wealth held its Heron Therapeutics (HRTX) position steady in Q3 2026 at 41,590 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #350.

HORAN Wealth first reported a position in HRTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $54.1K in Q1 2026. 135 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.

  • HORAN Wealth held 41,590 shares of Heron Therapeutics worth $13K as of Q3 2026.
  • HORAN Wealth left its Heron Therapeutics share count unchanged in Q3 2026.
  • Heron Therapeutics made up ﹤0.01% of HORAN Wealth's portfolio in Q3 2026, its #350 holding.
  • HORAN Wealth first reported a position in Heron Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • HORAN Wealth's Heron Therapeutics position peaked at $54.1K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.

Based on HORAN Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.